Dementias Terminated Phase 3 Trials for Risperidone (DB00734)

Also known as: Dementia / Dementia NOS / Amentia

IndicationStatusPhase
DBCOND0060453 (Dementias)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02374567Pharmacovigilance in Gerontopsychiatric PatientsTreatment
NCT00287742A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's DiseaseTreatment